Class information for:
Level 2: CA 125//CYFRA 21 1//HE4

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1190 8866 30.1 71%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
113 67759 ENDOMETRIOSIS//OBSTETRICS & GYNECOLOGY//GYNECOLOGIC ONCOLOGY

Classes in level below (level 1)


ID, lev. below Publications Label for level below
3369 1924 CA 125//HE4//HUMAN EPIDIDYMIS PROTEIN 4
8148 1214 CEACAM1//BILIARY GLYCOPROTEIN//CD66A
8708 1157 CA 19 9//CA19 9//SPAN 1
8920 1137 CA 242//PREOPERATIVE CEA LEVEL//POSTOPERATIVE SURVEILLANCE
9957 1040 CYFRA 21 1//CYTOKERATIN 19 FRAGMENTS//PROGRP
11044 946 CA 15 3//CA 153//TISSUE POLYPEPTIDE SPECIFIC ANTIGEN
12521 837 P53 AUTOANTIBODIES//ANTI P53 ANTIBODY//SERUM P53 ANTIBODY
18694 473 SQUAMOUS CELL CARCINOMA ANTIGEN//SCC ANTIGEN//SERPINB3
30418 138 GEL FIBERGLASS//TERATOL EXPT ONCOL//RAT COLON CANCER

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CA 125 Author keyword 415 47% 7% 645
2 CYFRA 21 1 Author keyword 314 82% 2% 183
3 HE4 Author keyword 255 89% 1% 115
4 CEA Author keyword 209 40% 5% 408
5 CARCINOEMBRYONIC ANTIGEN Author keyword 172 32% 5% 443
6 CA 19 9 Author keyword 124 51% 2% 174
7 TUMOR MARKERS Author keyword 120 25% 5% 414
8 CA 15 3 Author keyword 110 63% 1% 112
9 SQUAMOUS CELL CARCINOMA ANTIGEN Author keyword 108 70% 1% 90
10 TUMOR MARKER Author keyword 107 24% 4% 397

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CA 125 415 47% 7% 645 Search CA+125 Search CA+125
2 CYFRA 21 1 314 82% 2% 183 Search CYFRA+21+1 Search CYFRA+21+1
3 HE4 255 89% 1% 115 Search HE4 Search HE4
4 CEA 209 40% 5% 408 Search CEA Search CEA
5 CARCINOEMBRYONIC ANTIGEN 172 32% 5% 443 Search CARCINOEMBRYONIC+ANTIGEN Search CARCINOEMBRYONIC+ANTIGEN
6 CA 19 9 124 51% 2% 174 Search CA+19+9 Search CA+19+9
7 TUMOR MARKERS 120 25% 5% 414 Search TUMOR+MARKERS Search TUMOR+MARKERS
8 CA 15 3 110 63% 1% 112 Search CA+15+3 Search CA+15+3
9 SQUAMOUS CELL CARCINOMA ANTIGEN 108 70% 1% 90 Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN
10 TUMOR MARKER 107 24% 4% 397 Search TUMOR+MARKER Search TUMOR+MARKER

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CA 125 462 47% 8% 720
2 CEA 428 52% 7% 589
3 CA 19 9 300 55% 4% 372
4 CARCINOEMBRYONIC ANTIGEN 247 22% 11% 981
5 BILIARY GLYCOPROTEIN 238 77% 2% 164
6 TUMOR MARKERS 219 30% 7% 622
7 CA 15 3 214 71% 2% 174
8 CYFRA 21 1 174 61% 2% 185
9 C CAM 164 81% 1% 100
10 TISSUE POLYPEPTIDE ANTIGEN 145 69% 1% 124

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 JOURNAL OF TUMOR MARKER ONCOLOGY 18 30% 1% 50
2 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 13 12% 1% 100
3 JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES 6 12% 0% 43
4 TUMOUR BIOLOGY 2 15% 0% 13

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis 2015 3 35 74%
Systematic review: Serum autoantibodies in the early detection of gastric cancer 2015 3 50 62%
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues 1999 455 84 80%
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association 2014 13 62 79%
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer 2007 187 50 72%
p53 antibodies in the sera of patients with various types of cancer: A review 2000 331 131 67%
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer 2012 48 32 72%
THE CLINICAL UTILITY OF THE CA 19-9 TUMOR-ASSOCIATED ANTIGEN 1990 320 36 97%
Serum autoantibodies in the early detection of esophageal cancer: a systematic review 2015 1 57 70%
CARCINOEMBRYONIC ANTIGEN GENE FAMILY - MOLECULAR-BIOLOGY AND CLINICAL PERSPECTIVES 1991 512 181 46%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 TERATOL EXPT ONCOL 12 75% 0.1% 9
2 SURG BIOL 9 83% 0.1% 5
3 CNR IBPM 8 75% 0.1% 6
4 ONCIMMUNE LTD 8 75% 0.1% 6
5 TUMOR MARKERS 5 43% 0.1% 9
6 IMMUNOCHEM GLYCOBIOL 5 63% 0.1% 5
7 EXCELLENCE AUTOIMMUN CANC 4 67% 0.0% 4
8 CENT ISOTOP 4 75% 0.0% 3
9 HENAN TUMOR EPIDEMIOL 4 41% 0.1% 7
10 BIOMARKERS EMERGING TECHNOL 3 100% 0.0% 3

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000012844 MUC1//MUCIN//MUC5AC
2 0.0000011179 INTRAPERITONEAL CHEMOTHERAPY//CYTOREDUCTIVE SURGERY//PERITONEAL CARCINOMATOSIS
3 0.0000010653 STRUMA OVARII//OVARIAN CANCER//OVARIAN NEOPLASMS
4 0.0000010231 RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM
5 0.0000008574 GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO
6 0.0000007302 EXPERIMENTAL LEPROSY//IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX
7 0.0000006978 SMALL CELL LUNG CANCER//BOMBESIN//GASTRIN RELEASING PEPTIDE
8 0.0000006497 GANGLIOSIDES//SIALYLTRANSFERASE//SIALIC ACID
9 0.0000006393 CIRCULATING TUMOR CELLS//DISSEMINATED TUMOR CELLS//UTEROGLOBIN
10 0.0000006296 PANCREATIC CANCER//PANCREATICODUODENECTOMY//PANCREATIC FISTULA